|
Match
|
Document |
Document Title |
|
|
US20110171201 |
Formulation for Oral Administration of Proteins
Pharmaceutical formulations of orally administered proteins can be stabilized from oxidative degradation and inactivation in the stomach and GI tract by the addition of an antioxidant. |
|
|
US20130287756 |
COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN
Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found with krill oil and/or marine oil in combination with other... |
|
|
US20110020316 |
COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN
Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found with krill oil and/or marine oil in combination with other... |
|
|
US20130315890 |
Extramuscular treatment of traumatic-induced migraine headache
A method for selection and treatment of externally caused migraine headache, the method includes identifying a patient group having chronic migraine headache; determining the identified patient... |
|
|
US20110189159 |
METHODS AND COMPOSITIONS FOR PROTEIN DELIVERY
The present invention provides methods and compositions for protein delivery. The invention features virus like particles, methods of making virus like particles and methods of using virus like... |
|
|
US20110076316 |
SCALABLE MATRIX FOR THE IN VIVO CULTIVATION OF BONE AND CARTILAGE
The present invention provides implantable receptacle devices (and methods) for use in bone and tissue regeneration which provide immediate structural stability and strength to a zone where tissue... |
|
|
US20150231068 |
Treatment of Migraine Headaches with Presynaptic Neurotoxin
The present invention provides a method for treating a patient for migraine headache, including symptoms associated with migraine headache, such as migraine associated vertigo, which comprises... |
|
|
US20110318329 |
METHOD OF TREATMENT OR PROPHYLAXIS
The present invention is directed to methods and agents that are useful in the prevention and amelioration of signs and symptoms associated with neuropathic conditions. More particularly, the... |
|
|
US20130236444 |
TREATMENT OF MIGRAINE HEADACHE WITH DIFFUSION OF TOXIN IN NON-MUSCLE RELATED FORAMINAL SITES
A method for treating a patient with migraine headache includes administering to the patient a therapeutically effective amount of an invertebrate presynaptic neurotoxin in a pharmaceutically safe... |
|
|
US20120114628 |
COSMETIC AND THERAPEUTIC USE OF PROTEINS OF DJ-1 TYPE FOR TREATING SKIN DRYNESS
The present invention relates to the use, especially the cosmetic and/or therapeutic use, of the protein DJ-1, of polypeptides derived from this protein or of analogues thereof, of a nucleic acid... |
|
|
US20110243937 |
TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
The present application provides methods of prevention and/or treatment of breast cancer in a subject by inhibiting expression of PAX2. In the cancer treatment methods disclosed, the method of... |
|
|
US20110305633 |
Methods for Treatment, the Prognostic Assessment and the Detection of Breast Cancer
The present invention relates to methods for the treatment, the prognostic assessment and the detection of breast cancer. |
|
|
US20140328818 |
Proteases for Degrading Gluten
Gluten-degrading proteases derived from insects, including flour beetles, are isolated, and the purified, and recombinant forms can be used to make gluten-containing food safe for patients... |
|
|
US20130045195 |
Proteases for Degrading Gluten
Gluten-degrading proteases derived from insects, including flour beetles, are isolated, and the purified, and recombinant forms can be used to make gluten-containing food safe for patients... |
|
|
US20110300161 |
Methods for the Treatment and the Prognostic Assessment of Malignant Pleural Mesothelioma
The present invention relates to methods for the treatment and the prognostic assessment of malignant pleural mesothelioma. |
|
|
US20140010802 |
SYSTEMS AND METHODS FOR DIAGNOSING A PREDISPOSITION TO DEVELOP CANCER
Systems, methods, and computer readable media for diagnosing or characterizing a genetic predisposition to develop cancer, including cancers of the BAP1 cancer syndrome, are provided. Nucleic... |
|
|
US20100303798 |
Methods of Treating Urogenital-Neurological Disorders Using Neurotrophin Retargeted Endopepidases
The present specification discloses TVEMPs, compositions comprising such toxins and methods of treating urogenital-neurological disorders in a mammal using such TVEMPs and compositions. |
|
|
US20110274682 |
METHODS FOR PROTEASE ASSISTED PROTEIN DELIVERY
A method for intracellular delivery of single proteins or other cargo molecules by encapsulation within nanocapsules formed by interfacial polymerization of one or more types of monomers and... |
|
|
US20120093802 |
BIOACTIVE COMPOSITION INCLUDING STABILIZED PROTEIN AND PROCESS FOR PRODUCING THE SAME
A bioactive composition includes a porous hydrogel matrix. At least one protein is immobilized in the porous hydrogel matrix forming a hydrogel protein composite that is stable in an organic... |
|
|
US20140086867 |
Systems, Compositions and Methods for the Treatment of Alopecia
A method of inducing or promoting hair growth on the scalp of a subject, comprising the steps of (i) providing an ECM composition including at least one ECM material, (ii) administering inciting... |
|
|
US20140248258 |
METHODS FOR IMPROVING GUT HEALTH
The present invention provides methods for improving gut health. In particular, the invention provides methods for improving gut health by improving the digestibility of dietary proteins,... |
|
|
US20120225050 |
METHODS FOR IMPROVING GUT HEALTH
The present invention provides methods for improving gut health. In particular, the invention provides methods for improving gut health by improving the digestibility of dietary proteins,... |
|
|
US20150118154 |
METHODS FOR THE TREATMENT, THE PROGNOSTIC ASSESSMENT AND THE STAGING OF NON-SMALL CELL LUNG CANCER
The present invention relates to methods for the treatment, the prognosis and the diagnosis of non-small cell lung cancer. |
|
|
US20130224172 |
METHODS OF TREATING BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS
Disclosed herein are methods of using coated digestive enzyme preparations and enzyme delivery systems and pharmaceutical compositions comprising the preparations for treatment of subjects having... |
|
|
US20120156253 |
Enzyme Treatment of Foodstuffs for Celiac Sprue
Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects... |
|
|
US20110293724 |
Enzyme Treatment of Foodstuffs for Celiac Sprue
Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects... |
|
|
US20100310544 |
COMPOSITION COMPRISING CALCIUM IONS AND AT LEAST ONE PROTEOLYTIC ENZYME FOR USE IN THE IN VITRO AND IN VIVO REGENERATION OF CUTANEOUS AND CONNECTIVE TISSUES
The invention is based on the finding that calcium ions and proteolytic enzymes, particularly papain, act in a synergetic way in the regeneration of skin and connective tissues. Thus, such a... |
|
|
US20140148642 |
Magic genie developer
Apparatus and formulations for correcting and curing erectile dysfunction in men to create a natural erection without the use of primitive devices. the formulations will correct and cure erectile... |
|
|
US20150023949 |
COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
Methods for treatment and diagnosis of pervasive developmental disorders in humans are described. |
|
|
US20130224178 |
Methods of Treating Cancer Using Glucagon-Like Hormone Retargeted Endopepidases
The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating cancer in a mammal using such TVEMP compositions. |
|
|
US20130166040 |
REAGENTS AND METHODS FOR PREPARING TEETH FOR IMPLANTATION
The invention provides reagents and method for replacing teeth lost to periodontitis and other diseases and disorders resulting in tooth loss, and provides materials and methods that result in... |
|
|
US20120076768 |
DIGESTIVE/LAXATIVE COMPOSITIONS
Described are digestive/laxative compositions and methods of manufacture and use of same. In a preferred embodiment, the invention provides for a digestive/laxative composition including... |
|
|
US20110318342 |
METHODS OF USING IL-1 ANTAGONISTS TO TREAT AUTOINFLAMMATORY DISEASE
Methods of treating, inhibiting, or ameliorating an autoinflammatory disorder, disease, or condition in a subject in need thereof, comprising administering to a subject in need a therapeutic... |
|
|
US20110076260 |
Proteases Producing an Altered Immunogenic Response and Methods of Making and Using the Same
The present invention provides novel protein variants that exhibit reduced immunogenic responses, as compared to the parental proteins. The present invention further provides DNA molecules that... |
|
|
US20140335046 |
Compositions, Methods and Systems for Regenerative Cosmetics
A method of inducing or promoting hair growth on the scalp of a subject, comprising the steps of (i) providing an ECM composition including at least one ECM material, (ii) administering inciting... |
|
|
US20140219954 |
DRY POWDER FORMULATIONS OF ORGANIC MACROMOLECULES
The present invention relates to methods for making a stabilized powder formulation for inhalation comprising a macromolecule in lyophilized form, a crystalline carrier material, and magnesium... |
|
|
US20110123573 |
Methods and compositions for treating phenylketonuria
Provided herein are methods for treating a subject suffering from phenylketonuria by administering a phenylalanine hydroxylase (“PAH”) and/or a phenylalanine ammonia lyase (“PAL”) to the subject... |
|
|
US20120230976 |
ROTHIA SPECIES GLUTAMINE ENDOPEPTIDASES AND USE THEREOF
Disclosed are glutamine endopeptidase enzymes from Rothia sp. bacteria that are naturally associated with the oral cavity, formulations comprising the glutamine endopeptidase enzymes and the use... |
|
|
US20080206224 |
MUSCLE CONTRACTION TREATMENT UTILIZING BOTULINUM TOXIN
The invention provides for the use of a botulinum toxin to treat contracture, such as muscle contracture, in patients by transdermal administration of the botulinum toxin. |
|
|
US20140120077 |
Compositions and Methods for Safe Treatment of Rhinitis
Methods for treating rhinitis in a subject are provided herein. The methods of the present invention comprise intranasal administration of a topical composition comprising a purified botulinum... |
|
|
US20110086017 |
Medical Food composition and methods for management of inflammatory processes in mammals
A medical food composition, containing at least source of milk protein derived from milk producing animals, exposed to immune stimulants during pregnancy and lactation period, source of... |
|
|
US20110117074 |
METHODS OF TREATING HIV AND INFLUENZA INFECTIONS USING ASPERGILLUS ORYZAE PROTEASE
The invention provides methods for treating viral diseases such as HIV infection and influenza infection in a subject in need of treatment, comprising orally administering to the subject a... |
|
|
US20120244140 |
SCREENING METHOD FOR SUBSTANCE CAPABLE OF PROMOTING RECOVERY OF SKIN BARRIER FUNCTION TECHNICAL FIELD
The present invention provides a screening method for a substance capable of promoting recovery of skin barrier function, wherein the method comprises the steps of incubating caspase-14 and... |
|
|
US20110020270 |
TREATMENT AND PROPHYLAXIS
This invention discloses the use of an E-selectin antagonist and a mobilizer of hematopoietic stem cells or progenitor cells in methods and compositions for treating or preventing... |
|
|
US20110177056 |
NON-CYTOTOXIC FUSION PROTEINS COMPRISING EGF MUTEINS
The present invention relates to fusion proteins comprising a non-cytotoxic protease and a EGF mutein ligand. The EGF mutein provides improved EGF receptor activation for the claimed fusion... |
|
|
US20110020315 |
TREATMENT OF INFLAMMATORY ILLNESSES WITH ACE2
The present invention relates to ACE2 for the therapeutic treatment or prevention of inflammation. |
|
|
US20110044999 |
IL-32 MODULATORS
The present invention relates to methods of screening for modulators of interleukin 32 (IL-32), to modulators of IL-32 and to their use. |
|
|
US20120321611 |
Replenishment and Enrichment of Ocular Surface Lubrication
An ophthalmic composition, and methods of use thereof, including for treating ocular boundary deficiency, symptoms associated therewith, or undesired condition that is associated with or causes... |
|
|
US20110130783 |
TREATMENT OF OBESITY AND RELATED DISORDERS
This disclosure provides a method of treating obesity and related disorders through the administration of a composition comprising a neurotoxin and a mucosal permeabilizing agent. Methods for... |
|
|
US20120121612 |
FERMENTED WHEAT GERM PROTEINS (FWGP) FOR THE TREATMENT OF CANCER
The present invention provides compositions comprising the component of fermented wheat germ extract (“FWGE”) active in reducing, inhibiting or preventing the proliferation of cancer cells and/or... |